BPH Global Ltd - Asset Resilience Ratio

Latest as of June 2023: 33.28%

BPH Global Ltd (BP8) has an Asset Resilience Ratio of 33.28% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BPH Global Ltd (BP8) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$630.00K
≈ $445.77K USD Cash + Short-term Investments

Total Assets

AU$1.89 Million
≈ $1.34 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2023)

This chart shows how BPH Global Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see BPH Global Ltd total assets.

Liquid Assets Composition Over Time

This chart breaks down BPH Global Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of BPH Global Ltd to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$0.00 0%
Short-term Investments AU$630.00K 33.28%
Total Liquid Assets AU$630.00K 33.28%

Asset Resilience Insights

  • Very High Liquidity: BPH Global Ltd maintains exceptional liquid asset reserves at 33.28% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

BPH Global Ltd Industry Peers by Asset Resilience Ratio

Compare BPH Global Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
Drug Manufacturers - Specialty & Generic 47.16%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Piramal Pharma Limited
NSE:PPLPHARMA
Drug Manufacturers - Specialty & Generic 0.73%
Harbin Gloria Pharmaceuticals
SHE:002437
Drug Manufacturers - Specialty & Generic 9.04%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%

Annual Asset Resilience Ratio for BPH Global Ltd (2016–2023)

The table below shows the annual Asset Resilience Ratio data for BPH Global Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-06-30 29.99% AU$630.83K
≈ $446.35K
AU$2.10 Million
≈ $1.49 Million
+20.99pp
2022-06-30 8.99% AU$685.56K
≈ $485.08K
AU$7.62 Million
≈ $5.39 Million
-47.94pp
2021-06-30 56.93% AU$5.26 Million
≈ $3.72 Million
AU$9.23 Million
≈ $6.53 Million
-28.68pp
2020-06-30 85.61% AU$866.83K
≈ $613.34K
AU$1.01 Million
≈ $716.46K
+7.41pp
2019-06-30 78.19% AU$1.90 Million
≈ $1.35 Million
AU$2.43 Million
≈ $1.72 Million
+9.51pp
2018-06-30 68.69% AU$1.09 Million
≈ $768.68K
AU$1.58 Million
≈ $1.12 Million
+29.01pp
2017-06-30 39.67% AU$1.04 Million
≈ $739.09K
AU$2.63 Million
≈ $1.86 Million
+39.32pp
2016-06-30 0.35% AU$17.14K
≈ $12.13K
AU$4.88 Million
≈ $3.45 Million
--
pp = percentage points

About BPH Global Ltd

AU:BP8 Australia Drug Manufacturers - Specialty & Generic
Market Cap
$19.98 Million
AU$28.24 Million AUD
Market Cap Rank
#29903 Global
#1732 in Australia
Share Price
AU$0.01
Change (1 day)
+9.09%
52-Week Range
AU$0.00 - AU$0.02
All Time High
AU$2.05
About

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics… Read more